DLB:NYE-Dolby Laboratories (USD)

COMMON STOCK | Specialty Business Services |

Last Closing

USD 80.63

Change

+0.02 (+0.02)%

Market Cap

N/A

Volume

0.41M

Analyst Target

USD 76.25
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Specialty Business Services

Symbol Name Price(Change) Market Cap
RBA RB Global Inc.

N/A

USD 16.40B
ARMK Aramark Holdings

-0.06 (-0.15%)

USD 10.37B
ULS UL Solutions Inc.

-0.10 (-0.19%)

USD 9.77B
AMTM Amentum Holdings Inc.

-0.36 (-1.81%)

USD 6.44B
CBZ CBIZ Inc

-0.65 (-0.76%)

USD 4.24B
UNF Unifirst Corporation

-7.15 (-3.19%)

USD 4.10B
ABM ABM Industries Incorporated

+0.15 (+0.28%)

USD 3.23B
AZZ AZZ Incorporated

+0.19 (+0.22%)

USD 2.55B
BV BrightView Holdings

+0.27 (+1.74%)

USD 1.49B
QUAD Quad Graphics Inc

-0.35 (-4.92%)

USD 0.35B

ETFs Containing DLB

OUSM O’Shares U.S. Small-Cap.. 2.25 % 0.48 %

-0.28 (-0.63%)

USD 0.87B
CSF VictoryShares US Discover.. 0.35 % 0.35 %

-0.08 (-0.63%)

USD 0.04B
CSA VictoryShares US Small Ca.. 0.35 % 0.35 %

-0.15 (-0.63%)

USD 0.04B

Market Performance

  Market Performance vs. Industry/Classification (Specialty Business Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.24% 54% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.24% 54% F 64% D
Trailing 12 Months  
Capital Gain -3.07% 27% F 24% F
Dividend Return 1.08% 33% F 17% F
Total Return -1.98% 27% F 20% F
Trailing 5 Years  
Capital Gain 16.28% 47% F 56% F
Dividend Return 6.95% 33% F 19% F
Total Return 23.23% 47% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 5.94% 41% F 54% F
Dividend Return 7.14% 41% F 50% F
Total Return 1.20% 38% F 28% F
Risk Return Profile  
Volatility (Standard Deviation) 27.52% 55% F 39% F
Risk Adjusted Return 25.93% 55% F 40% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector